• slide
  • slide
  • slide
  • slide
  • slide
  • slide

R & D PortFolio

TherDose is capable of developing, scaling up and commercializing various dosage forms spread across parenteral (solutions, suspensions, lyophilized), orals (tablets, capsules, soft gels, oral liquids), and many others.

The major focus is to develop and manufacture products for US and EU.

Highly customized infrastructure to accommodate the R&D and production

More efficient scientists with various specializations are dedicated to development of finished dosage forms.

Process Development and Scale-up Labs are attached to the manufacturing unit.